Browsing Tag
synthetic tissue matrices
1 post
Solventum (NYSE: SOLV) stock jumps 5% on $850m Acera Surgical acquisition deal
Solventum’s $850M Acera deal aims to reshape wound care strategy. See how synthetic matrices and Restrata could drive long-term growth.